Richard A. Graham - 14 Jun 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, RESEARCH & DEVELOPMENT
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
14 Jun 2023
Net transactions value
-$24,822
Form type
4
Filing time
16 Jun 2023, 18:14:04 UTC
Previous filing
23 May 2023
Next filing
18 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale $24,822 -2,322 -0.65% $10.69 354,390 14 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.